Direct Pharma Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Direct Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing

Secondary Activities: All Other Food Manufacturing | All Other Miscellaneous Food Manufacturing | Toilet Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Full name: Direct Pharma Sp. z o.o.

Profile Updated: May 12, 2024

Direct Pharma Sp. z o.o. is an enterprise based in Poland. Its main office is in Krakow. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on March 14, 2016. It currently has a total number of 1 (2016) employees. In 2023, the company reported a net sales revenue drop of 15.29%. Its total assets grew by 14.29% over the same period. Direct Pharma Sp. z o.o.’s net profit margin increased by 339.73% in 2023.

Headquarters
Ul. Zygmunta Radnickiego 11
Krakow; Malopolskie; Postal Code: 30-498

Contact Details: Purchase the Direct Pharma Sp. z o.o. report to view the information.

Basic Information

Total Employees:

Purchase the Direct Pharma Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Direct Pharma Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Direct Pharma Sp. z o.o. report to view the information.

Incorporation Date:

March 14, 2016

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

91%

Company Performance

Financial values in the chart are available after Direct Pharma Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-15.29%▼

Total operating revenue

-11.98%▼

Operating profit (EBIT)

60.94%▲

Net Profit (Loss) for the Period

60.94%▲

Total assets

14.29%▲

Total equity

-11.54%▼

Operating Profit Margin (ROS)

339.73%▲

Net Profit Margin

339.73%▲

Return on Equity (ROE)

-19.2%▼

Similar companies